Cancer Biology & Medicine

In this issue, Prof. Wanqing Chen reviewed trends of cancer burden and risk factors in China. Prof. Junjie Chen’s review elucidated biological and clinical characteristics of HPV-related cancers. Besides, reviews about basic researches focus on cancer evolution and tumor microenvironment.

Original studies included new findings on mechanism of tumorigenesis and cancer development as well as novel discoveries in diagnosis and treatment for hepatocellular carcinoma, breast cancer, gastric cancer, and so on. We hope this issue will greatly benefit your research and clinical practice. Welcome to submit your work to Cancer Biology & Medicine.

As a global public health event, coronavirus disease (COVID-19) pandemic affects people’s health and routine life severely this year. For cancer patients with COVID-19, it’s very important to study their risks, clinical features, therapeutics, medical cares, and so on. In this issue, Prof. Xiaoping Miao and Xiaojiang Cui contribute an editorial and a review on this topic, respectively.

Several papers on basic researches focus the roles of some molecules in the tumorigenesis and cancer development, such as CMTM family proteins, Anoctamin 7 (ANO7), PRAS40, and SHP2. What’s more, reviews and original researches on clinical oncology would be attractive as well to readers. The contents refer to management strategy for papillary thyroid microcarcinoma, immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients, and outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type.

We hope this issue will greatly benefit your research and clinical practice. Welcome to submit your work to Cancer Biology & Medicine.